Function and therapeutic value of astrocytes in diabetic cognitive impairment
Neurochemistry International · 2023-10 · 169 · 105591
DOI: 10.1016/j.neuint.2023.105591 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurochemistry International, 2023-10. Verfasst von Fanyu Meng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Cognitive Dysfunction. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 258 Literaturangaben.
Abstract (Originalsprache)
Diabetic cognitive impairment (DCI) is a complex complication of diabetes in the central nervous system, and its pathological mechanism is still being explored. Astrocytes are abundant glial cells in central nervous system that perform diverse functions in health and disease. Accumulating excellent research has identified astrocyte dysfunction in many neurodegenerative diseases (such as Alzheimer's disease, aging and Parkinson's disease), and summarized and discussed its pathological mechanisms and potential therapeutic value. However, the contribution of astrocytes to DCI has been largely overlooked. In this review, we first systematically summarized the effects and mechanisms of diabetes on brain astrocytes, and found that the diabetic environment (such as hyperglycemia, advanced glycation end products and cerebral insulin resistance) mediated brain reactive astrogliosis, which was specifically reflected in the changes of cell morphology and the remodeling of signature molecules. Secondly, we emphasized the contribution and potential targets of reactive astrogliosis to DCI, and found that reactive astrogliosis-induced increased blood-brain barrier permeability, glymphatic system dysfunction, neuroinflammation, abnormal cell communication and cholesterol metabolism dysregulation worsened cognitive function. In addition, we summarized effective strategies for treating DCI by targeting astrocytes. Finally, we discuss the application of new techniques in astrocytes, including single-cell transcriptome, in situ sequencing, and prospected new functions, new subsets and new targets of astrocytes in DCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
- Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China; State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China; Haihe Lab…
- State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China; Haihe Laboratory of Modern Chinese Medicine, Tianjin, 301617, China; First Teaching H…
Zitieren
APA
Meng, F., Fu, J., Zhang, L., Guo, M., Zhuang, P., Yin, Q., & Zhang, Y. (2023). Function and therapeutic value of astrocytes in diabetic cognitive impairment. Neurochemistry International, 169, 105591. https://doi.org/10.1016/j.neuint.2023.105591
Vancouver
Meng F, Fu J, Zhang L, Guo M, Zhuang P, Yin Q, et al. Function and therapeutic value of astrocytes in diabetic cognitive impairment. Neurochemistry International. 2023;169:105591. doi:10.1016/j.neuint.2023.105591
BibTeX
@article{Meng2023,
author = {Meng, Fanyu and Fu, Jiafeng and Zhang, Lin and Guo, Mengqing and Zhuang, Pengwei and Yin, Qingsheng and Zhang, Yanjun},
title = {Function and therapeutic value of astrocytes in diabetic cognitive impairment},
journal = {Neurochemistry International},
year = {2023},
volume = {169},
pages = {105591},
doi = {10.1016/j.neuint.2023.105591}
}
EUVIMED